271980.KS
Jeil Pharmaceutical Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 10,780.00
−1.01%Margins
Gross margin
39.1%
EBITDA margin
4.6%
EBIT margin
0.5%
Net margin
1.7%
FCF margin
-1.1%
4.5%
Return on equity
1.8%
Return on assets
0.9%
Return on invested capital
1.04x
Asset turnover
KRW 7.9B
Cash from operations
KRW 7.7K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026